Overview
Cancilico, a Dresden-based AI diagnostics startup focused on blood cancers, has raised €2.5 million in a seed round to expand commercialization and pursue regulatory pathways for its bone marrow analysis software, Myeloaid. The financing was led by a syndicate including High-Tech Gründerfonds (HTGF), TGFS – Technologiegründerfonds Sachsen, Gedad GmbH, and ROI Verwaltungsgesellschaft.
Products
Loading...
Recent Deals
Investors: High-Tech Gründerfonds (HTGF), TGFS – Technologiegründerfonds Sachsen, Gedad GmbH, ROI Verwaltungsgesellschaft
Cancilico, a Dresden-based AI diagnostics startup focused on blood cancers, has raised €2.5 million in a seed round to expand commercialization and pursue regulatory pathways for its bone marrow analysis software, Myeloaid. The financing was led by a syndicate including High-Tech Gründerfonds (HTGF), TGFS – Technologiegründerfonds Sachsen, Gedad GmbH, and ROI Verwaltungsgesellschaft.